These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9704702)

  • 21. Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina.
    Yazdani S; Simon AD; Kovar L; Wang W; Schwartz A; Rabbani LE
    J Am Coll Cardiol; 1997 Nov; 30(5):1284-7. PubMed ID: 9350928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
    Liuzzo G; Santamaria M; Biasucci LM; Narducci M; Colafrancesco V; Porto A; Brugaletta S; Pinnelli M; Rizzello V; Maseri A; Crea F
    J Am Coll Cardiol; 2007 Jan; 49(2):185-94. PubMed ID: 17222729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease.
    Yilmaz A; Weber J; Cicha I; Stumpf C; Klein M; Raithel D; Daniel WG; Garlichs CD
    J Am Coll Cardiol; 2006 Jul; 48(1):70-80. PubMed ID: 16814651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
    Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
    Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
    Robertson L; Grip L; Mattsson Hultén L; Hulthe J; Wiklund O
    J Intern Med; 2007 Dec; 262(6):659-67. PubMed ID: 17927738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
    Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.
    Krempl TK; Maas R; Sydow K; Meinertz T; Böger RH; Kähler J
    Eur Heart J; 2005 Sep; 26(18):1846-51. PubMed ID: 15860520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
    Waehre T; Yndestad A; Smith C; Haug T; Tunheim SH; Gullestad L; Frøland SS; Semb AG; Aukrust P; Damås JK
    Circulation; 2004 Apr; 109(16):1966-72. PubMed ID: 15051633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High telomerase activity in neutrophils from unstable coronary plaques.
    Narducci ML; Grasselli A; Biasucci LM; Farsetti A; Mulè A; Liuzzo G; La Torre G; Niccoli G; Mongiardo R; Pontecorvi A; Crea F
    J Am Coll Cardiol; 2007 Dec; 50(25):2369-74. PubMed ID: 18154960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selected inflammatory markers in patients with acute coronary syndrome].
    Kubik L; Gajewski M; Stankiewicz W; Płocharski A; Skolimowska B; Karpiński M; Dabrowski M; Szmigielski S; Kosior J; Pecak R
    Pol Merkur Lekarski; 2002 Jul; 13(73):32-5. PubMed ID: 12362502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina.
    Angelini A; Rubartelli P; Mistrorigo F; Della Barbera M; Abbadessa F; Vischi M; Thiene G; Chierchia S
    Circulation; 2004 Aug; 110(5):515-21. PubMed ID: 15277328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DRBeta1, circulating Th1/Th2 cytokines and immunological homunculus in coronary atherosclerosis.
    Mostafazadeh A; Saravi M; Niaki HA; Drabbels J; Gholipour HM; Minagar M; Mosavi E; Jalali F; Bijani A
    Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):11-9. PubMed ID: 21358010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous transluminal coronary angioplasty in patients with unstable angina.
    Erbel R; Meyer J; Schmitz HJ; Kiesslich T; Effert S
    Postgrad Med J; 1983; 59 Suppl 3():22-5. PubMed ID: 6227879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of percutaneous transluminal coronary angioplasty for patients with unstable angina.
    Mahanonda N; Kangkagate C; Chotinaiwattarakul C; Chaithiraphan S
    J Med Assoc Thai; 1996 Jul; 79(7):454-9. PubMed ID: 8855625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous coronary angioplasty in stable and unstable angina.
    Faxon DP
    Cardiol Clin; 1991 Feb; 9(1):99-113. PubMed ID: 2029708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.